The University’s Institute of Translational Medicine has been awarded £1.8m funding from the UK National Institute of Health Research (NIHR) to run a large study into the drug treatment of bleeding after childbirth (also called postpartum haemorrhage or PPH).
PPH is often defined as the loss of more than 500ml or 1,000ml of blood within the first 24 hours following childbirth. It is a common maternity emergency affecting 40,000 British women each year. Although it can usually be treated in the UK, it can lead to long-lasting complications.
Globally, however, it remains a major cause of death and is responsible for around 25% of the 289,000 maternal deaths annually. It is estimated that somewhere in the world a woman dies from PPH every 6 minutes.
Most effective treatment?
Currently PPH is commonly treated injections of either oxytocin or carboprost.
Oxytocin is a natural hormone-like substance that causes the uterus to contract. Oxytocin is used to induce labour or strengthen labour contractions during childbirth, and to control bleeding after childbirth.
Carboprost is a form of prostaglandin (a hormone-like substance that occurs naturally in the body). Prostaglandins help to control functions in the body such as blood pressure and muscle contractions.
At this time it is not known which is more effective in the treatment of PPH.
The study, entitled the ‘Carboprost or Oxytocin Postpartum haemorrhage Effectiveness’ (COPE) study, will compare the use of these injections and will involve nearly 4,000 women with PPH from 40 hospitals around the UK.
Women taking part will receive one of the two injections, along with a matching dummy drug. In this way, no-one will know which drug they have received. It is only when the study is over and the codes are broken that the outcomes can be compared between the half who received oxytocin and the half who received carboprost.
Professor Andrew Weeks, Consultant Obstetrician at Liverpool Women’s Hospital and Chief Investigator for the study, said: “We are delighted to be part of this important study that has the chance to improve the care of so many women.
“Bleeding after childbirth can happen very quickly and it is important that we get the treatment right. This will allow women to get on with the important matter of caring for their new baby, rather than having to spend their time recovering.”
For more information about Professor Weeks’ research can be found here.
You must be logged in to post a comment.
All recent news
Obituary: Benny Pollack
Risk factors associated with severe and fatal cases of COVID-19 identified
Architecture academics on the view from your lockdown window
COVID-19 and alcohol – a dangerous cocktail
University lockdown lecturer engages with new audience online
"Just because Boris Johnson and the Prince of Wales have had #Covid19 doesn’t mean the disease strikes all people equally"
New @bmj_latest piece by @livuniHLS Profs Dame Margaret Whitehead, Ben Barr & David Taylor-Robinson #healthinequalities #LivUniCovid https://go.shr.lc/2LU5Gdm
We are not “all in it together”—less privileged in society are suffering the brunt of the damage https://blogs.bmj.com/bmj/2020/05/22/covid-19-we-are-not-all-in-it-together-less-privileged-in-society-are-suffering-the-brunt-of-the-damage/
@felly500 @BWDDPH @martinmckee @AbdulRazaq_PH @SimonCapewell99 @ProfBambra
Dr @soozaphone on @LivUniPsyc's new ‘Coping with COVID podcast’ that provides psychological support to medical, allied health professions and nursing students working in the #NHS during the #COVIDー19 pandemic.
More info https://bit.ly/2A5IOET